These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 25536529)
41. Evaluation of sparfloxacin eye drop in the management of conjunctival and corneal infection. Vyas U; Desai T; Shah C J Indian Med Assoc; 2002 Jun; 100(6):398-9. PubMed ID: 12416674 [TBL] [Abstract][Full Text] [Related]
42. Classifying the severity of corneal ulcers by using the "1, 2, 3" rule. Vital MC; Belloso M; Prager TC; Lanier JD Cornea; 2007 Jan; 26(1):16-20. PubMed ID: 17198008 [TBL] [Abstract][Full Text] [Related]
43. Monotherapy versus fortified antibiotics for bacterial keratitis. Rosenberg JB; Gritz DC Cornea; 2011 Sep; 30(9):1066; author reply 1066-7. PubMed ID: 21775886 [No Abstract] [Full Text] [Related]
44. How useful are scrapings in the treatment of corneal ulcers? Van Slycken S; Zeyen T Bull Soc Belge Ophtalmol; 1993; 249():117-23. PubMed ID: 7952340 [TBL] [Abstract][Full Text] [Related]
45. Infectious keratitis in keratoconus with corneal hydrops without contact lens wear: a case report. Jhanji V; Sharma N; Agarwal T; Titiyal JS Eye Contact Lens; 2008 Mar; 34(2):122-3. PubMed ID: 18327050 [TBL] [Abstract][Full Text] [Related]
50. Infectious keratitis after Boston type 1 keratoprosthesis implantation. Chan CC; Holland EJ Cornea; 2012 Oct; 31(10):1128-34. PubMed ID: 22960647 [TBL] [Abstract][Full Text] [Related]
51. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial. Bashir H; Dave A; Mathur U Cornea; 2016 Aug; 35(8):e22-3. PubMed ID: 27227400 [No Abstract] [Full Text] [Related]
52. Rationale for adjunctive topical corticosteroids in bacterial keratitis. Hindman HB; Patel SB; Jun AS Arch Ophthalmol; 2009 Jan; 127(1):97-102. PubMed ID: 19139348 [No Abstract] [Full Text] [Related]
53. Corneal ulcers and the use of topical fluoroquinolones. Honig MA; Cohen EJ; Rapuano CJ; Laibson PR CLAO J; 1999 Oct; 25(4):200-3. PubMed ID: 10555733 [TBL] [Abstract][Full Text] [Related]
54. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis. Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708 [TBL] [Abstract][Full Text] [Related]
56. Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone-treated bacterial keratitis. Wilhelmus KR; Abshire RL; Schlech BA Arch Ophthalmol; 2003 Sep; 121(9):1229-33. PubMed ID: 12963604 [TBL] [Abstract][Full Text] [Related]
57. [Orthokeratology induced infective corneal ulcer]. Lü L; Zou L; Wang R Zhonghua Yan Ke Za Zhi; 2001 Nov; 37(6):443-6. PubMed ID: 11840754 [TBL] [Abstract][Full Text] [Related]
58. Conrad Berens Lecture. The management of infectious keratitis as we approach the 21st century. Forster RK CLAO J; 1998 Jul; 24(3):175-80. PubMed ID: 9684077 [TBL] [Abstract][Full Text] [Related]
59. The Utility of Corneal Cultures in Bacterial Keratitis. Hsu J; Gupta A Eye Contact Lens; 2023 Aug; 49(8):329-333. PubMed ID: 37488724 [TBL] [Abstract][Full Text] [Related]
60. [Levofloxacin (Tavanic) in the treatment of corneal ulcers]. Maĭchuk IuF Antibiot Khimioter; 2003; 48(6):16-9. PubMed ID: 14558414 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]